Atrium Therapeutics Market Sentiment

SPY731.20−0.25%QQQ645.46−0.25%BTC/USD75,144.70−6.57%DIA512.19−0.40%GLD374.70−0.21%TLT81.90−0.04%

Premium Services

Atrium Therapeutics Inc

RNANASDAQ

Trade with Public

$8.32

-0.36-4.15%

Last update: Nov 4, 4:00 PM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Atrium Therapeutics Market Sentiment - Benzinga

Atrium Therapeutics Market Sentiment

Market sentiment signals for Atrium Therapeutics (RNA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

23 analysts

Options Flow (P/C)

—

Avg Consensus PT

$58

+563.8%

Highest Price Target

$96

+1006.0%

Cantor Fitzgerald

Lowest Price Target

$15

+72.8%

Roth Capital

Short Interest

6.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 28, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+130.4%	$25 → $20	Maintained	Buy
Oct 22, 2026	Roth Capital	Boobalan Pachaiyappan—	+72.8%	$15	Initiate	Buy
Aug 14, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+188.0%	$25 → $25	Maintained	Buy
Aug 6, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+188.0%	$25	Initiate	Buy
Jun 18, 2026	Cantor Fitzgerald	Kristen Kluska—	+188.0%	$25	Initiate	Overweight
May 15, 2026	Leerink Partners	Joseph Schwartz—	+188.0%	$25	Initiate	Outperform
May 1, 2026	HC Wainwright & Co.	Ananda Ghosh—	—	—	Suspends	Neutral
Mar 11, 2026	Wells Fargo	Yanan Zhu—	+188.0%	$25	Initiate	Overweight
Nov 11, 2025	Chardan Capital	Keay Nakae—	+729.5%	$72 → $72	Maintained	Neutral
Oct 29, 2025	TD Cowen	Ritu Baral—	+752.5%	$78 → $74	Downgrade	Buy→Hold
Oct 28, 2025	Chardan Capital	Keay Nakae—	+729.5%	$75 → $72	Downgrade	Buy→Neutral
Oct 28, 2025	RBC Capital	Luca Issi—	+729.5%	$61 → $72	Downgrade	Outperform→Sector Perform
Oct 27, 2025	Citigroup	Geoff Meacham—	+729.5%	$75 → $72	Downgrade	Buy→Neutral
Oct 27, 2025	Leerink Partners	Joseph Schwartz—	+729.5%	$65 → $72	Downgrade	Outperform→Market Perform
Oct 27, 2025	Raymond James	Martin Auster—	—	—	Downgrade	Strong Buy→Market Perform
Oct 27, 2025	Bernstein	William Pickering—	+729.5%	$52 → $72	Downgrade	Outperform→Market Perform
Oct 27, 2025	Needham	Joseph Stringer—	+648.8%	$65 → $65	Downgrade	Buy→Hold
Oct 27, 2025	HC Wainwright & Co.	Ananda Ghosh—	+729.5%	$87 → $72	Downgrade	Buy→Neutral
Sep 22, 2025	Evercore ISI Group	Josh Schimmer—	+648.8%	$70 → $65	Maintained	Outperform
Sep 17, 2025	Roth Capital	Boobalan Pachaiyappan—	+614.3%	$62	Initiate	Buy
Sep 15, 2025	B of A Securities	Geoff Meacham—	+648.8%	$56 → $65	Maintained	Buy
Sep 12, 2025	HC Wainwright & Co.	Ananda Ghosh—	+902.3%	$68 → $87	Maintained	Buy
Sep 10, 2025	Chardan Capital	Keay Nakae—	+764.1%	$75 → $75	Maintained	Buy
Sep 10, 2025	Needham	Joseph Stringer—	+648.8%	$60 → $65	Maintained	Buy
Aug 8, 2025	Wells Fargo	Yanan Zhu—	+764.1%	$70 → $75	Maintained	Overweight